Institutional investors purchased a net $2.8 million shares of OGEN during the quarter ended March 2014. This may signal that the smart money is gaining interest in this company as the 13.70% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 2.8 Million shares of Oragenics Inc
JANNEY MONTGOMERY SCOTT LLC (INV... Bought 39.4 Thousand shares of Oragenics Inc
THE VANGUARD GROUP, INC. Bought 12.5 Thousand shares of Oragenics Inc